research Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease 2 citations , September 2023 in “Curēus” Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.
research SYK inhibitor entospletinib prevents ocular and skin GVHD in mice 45 citations , October 2018 in “JCI Insight” Entospletinib effectively prevents eye and skin GVHD in mice.
research Mice Engrafted with Human Fetal Thymic Tissue and Hematopoietic Stem Cells Develop Pathology Resembling Chronic Graft-versus-Host Disease 47 citations , June 2013 in “Biology of blood and marrow transplantation” Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.
research High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole 2 citations , May 2017 in “The Journal of Dermatology” A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.
research Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood 16 citations , March 2017 in “Bone Marrow Transplantation” Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.